Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hallam TM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andreadi A; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Framlington Place Newcastle upon Tyne, NE2 4HH, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, United Kingdom., Hallam TM; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, 188 York Way, London, N7 9AS, United Kingdom., Brocklebank V; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Framlington Place Newcastle upon Tyne, NE2 4HH, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, United Kingdom., Sharp SJ; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, 188 York Way, London, N7 9AS, United Kingdom., Walsh PR; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Framlington Place Newcastle upon Tyne, NE2 4HH, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, United Kingdom., Southerington T; Finnish Biobank Cooperative Regus, Yliopistonkatu 31, 20100 Turku, Finland.; University of Turku, Hospital District of Southwest Finland, Finnish Biobank Cooperative - FINBB, Turku, Finland., Hautalahti M; Finnish Biobank Cooperative Regus, Yliopistonkatu 31, 20100 Turku, Finland., Steel DH; Biosciences Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, NE1 3BZ, United Kingdom.; Sunderland Eye Infirmary, Queen Alexandra Rd, Sunderland, SR2 9HP, United Kingdom., Lotery AJ; Clinical and Experimental Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO17 1BJ, United Kingdom., Harris CL; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Framlington Place Newcastle upon Tyne, NE2 4HH, United Kingdom.; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, 188 York Way, London, N7 9AS, United Kingdom., Marchbank KJ; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, United Kingdom.; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, 188 York Way, London, N7 9AS, United Kingdom., Kavanagh D; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Framlington Place Newcastle upon Tyne, NE2 4HH, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, United Kingdom., Jones AV; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, 188 York Way, London, N7 9AS, United Kingdom.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.
Autor:
Hallam TM; Gyroscope Therapeutics Limited, A Novartis Company, London, UK. Electronic address: thomas.hallam@novartis.com., Andreadi A; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Sharp SJ; Gyroscope Therapeutics Limited, A Novartis Company, London, UK., Brocklebank V; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Gardenal E; Gyroscope Therapeutics Limited, A Novartis Company, London, UK., Dreismann A; Gyroscope Therapeutics Limited, A Novartis Company, London, UK., Lotery AJ; Clinical and Experimental Sciences, Faculty of Medicine, University Hospital Southampton, University of Southampton, Southampton, UK., Marchbank KJ; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Harris CL; Gyroscope Therapeutics Limited, A Novartis Company, London, UK; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Jones AV; Gyroscope Therapeutics Limited, A Novartis Company, London, UK., Kavanagh D; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK. Electronic address: david.kavanagh@ncl.ac.uk.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Jul; Vol. 300 (7), pp. 107452. Date of Electronic Publication: 2024 Jun 07.
Autor:
Brocklebank V; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Walsh PR; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Smith-Jackson K; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Hallam TM; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Marchbank KJ; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Wilson V; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Bigirumurame T; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Dutt T; Department of Haematology, Royal Liverpool University Hospital, Liverpool, United Kingdom., Montgomery EK; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Malina M; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Great North Children's Hospital, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle, United Kingdom., Wong EKS; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Johnson S; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Great North Children's Hospital, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle, United Kingdom., Sheerin NS; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Kavanagh D; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Institute for Health and Care Research Newcastle Biomedical Research Centre, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.
Publikováno v:
Blood [Blood] 2023 Oct 19; Vol. 142 (16), pp. 1371-1386.
Autor:
Hallam TM; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, London N7 9AS, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK; National Renal Complement Therapeutics Centre, Building 26, Royal Victoria Infirmary, UK., Sharp SJ; Gyroscope Therapeutics Limited, A Novartis Company, Rolling Stock Yard, London N7 9AS, UK., Andreadi A; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK; National Renal Complement Therapeutics Centre, Building 26, Royal Victoria Infirmary, UK., Kavanagh D; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK; National Renal Complement Therapeutics Centre, Building 26, Royal Victoria Infirmary, UK; NIHR Newcastle Biomedical Research Centre, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK. Electronic address: david.kavanagh@newcastle.ac.uk.
Publikováno v:
Immunobiology [Immunobiology] 2023 Sep; Vol. 228 (5), pp. 152410. Date of Electronic Publication: 2023 Jun 05.
Autor:
Dreismann AK; Gyroscope Therapeutics Limited, London, UK., Hallam TM; Gyroscope Therapeutics Limited, London, UK., Tam LC; Gyroscope Therapeutics Limited, London, UK., Nguyen CV; Gyroscope Therapeutics Limited, London, UK., Hughes JP; Gyroscope Therapeutics Limited, London, UK., Ellis S; Gyroscope Therapeutics Limited, London, UK., Harris CL; Gyroscope Therapeutics Limited, London, UK.
Publikováno v:
Immunological reviews [Immunol Rev] 2023 Jan; Vol. 313 (1), pp. 402-419. Date of Electronic Publication: 2022 Nov 12.
Autor:
Hallam TM; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Cox TE; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Smith-Jackson K; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Brocklebank V; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Baral AJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Tzoumas N; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Steel DH; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Sunderland Eye Infirmary, Sunderland, United Kingdom.; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, United Kingdom., Wong EKS; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Shuttleworth VG; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Lotery AJ; Clinical and Experimental Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom., Harris CL; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Marchbank KJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Kavanagh D; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.; National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre, Biomedical Research Building, Newcastle upon Tyne, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Dec 28; Vol. 13, pp. 1028760. Date of Electronic Publication: 2022 Dec 28 (Print Publication: 2022).
Autor:
Kamala O; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Malik TH; Centre for Inflammatory Disease, Imperial College London, London, United Kingdom., Hallam TM; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Cox TE; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Yang Y; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Vyas F; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Luli S; Preclinical In Vivo Imaging, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Connelly C; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Gibson B; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Smith-Jackson K; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Denton H; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Pappworth IY; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Huang L; Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Kavanagh D; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Pickering MC; Centre for Inflammatory Disease, Imperial College London, London, United Kingdom., Marchbank KJ; Complement Therapeutics Research Group and National Renal Complement Therapeutics Centre, Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Dec 09; Vol. 12, pp. 752916. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).
Autor:
Wahid AA; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom., Dunphy RW; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom., Macpherson A; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.; UCB Pharma, Slough, United Kingdom., Gibson BG; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Kulik L; Division of Rheumatology, University of Colorado, Aurora, CO, United States., Whale K; UCB Pharma, Slough, United Kingdom., Back C; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom., Hallam TM; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Alkhawaja B; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom., Martin RL; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom., Meschede I; UCB Pharma, Slough, United Kingdom., Laabei M; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom., Lawson ADG; UCB Pharma, Slough, United Kingdom., Holers VM; Division of Rheumatology, University of Colorado, Aurora, CO, United States., Watts AG; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.; Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom., Crennell SJ; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom., Harris CL; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Marchbank KJ; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., van den Elsen JMH; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.; Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Aug 09; Vol. 12, pp. 714055. Date of Electronic Publication: 2021 Aug 09 (Print Publication: 2021).